  See all
 |
Articles: BMT/SCT |
Prior Articles
Donor KIR3DL1/3DS1 Gene and Recipient Bw4 KIR Ligand as Prognostic Markers for Outcome in Unrelated Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation, 09/18/09
Infectious Complications after Unrelated Umbilical Cord Blood Transplantation in Adult Patients with Hematologic Malignancies
Biology of Blood and Marrow Transplantation, 09/18/09 Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation, 09/18/09 Impact of Cyclosporine-A Concentration on the Incidence of Severe Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation, 09/18/09 Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement
Leukemia and Lymphoma, 09/18/09 Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study
Blood, 09/18/09 The role of B Cells in the pathogenesis of graft-versus-host disease
Blood, 09/18/09 Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation, 09/18/09 Impact of Conditioning Regimen in Allogeneic Hematopoetic Stem Cell Transplantation for Children with Acute Myelogenous Leukemia beyond First Complete Remission: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study
Biology of Blood and Marrow Transplantation, 09/18/09 Lung Function and Long-Term Complications after Allogeneic Hematopoietic Cell Transplant
Biology of Blood and Marrow Transplantation, 09/18/09 Functional performance status of hematopoietic SCT recipients in the sub-acute phase of recovery
Bone Marrow Transplantation, 09/17/09 In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells
Blood, 09/17/09 Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation, 09/16/09 Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen
Biology of Blood and Marrow Transplantation, 09/16/09 Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
Biology of Blood and Marrow Transplantation, 09/16/09 Impact of Declining Fertility Rates in Canada on Donor Options in Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, 09/16/09 Decision Analysis of Peripheral Blood versus Bone Marrow Hematopoietic Stem Cells for Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation, 09/16/09 Quantifying the Survival Benefit for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Acute Myelogenous Leukemia
Biology of Blood and Marrow Transplantation, 09/16/09 Busulfan and Cyclophosphamide (Bu/Cy) as a Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma: A Single-Institution Experience
Biology of Blood and Marrow Transplantation, 09/16/09 Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies
Biology of Blood and Marrow Transplantation, 09/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
